drugset / Trial / NCT02184325
Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children
RandomizedCrossoverDouble-blindTreatment
Summary
Study to evaluate the tolerability and safety of Kiddi® Pharmaton Fizz effervescent tablets, in children of 6 to 14 years, comparing a given formula with an improved one with reduced mineral content (qualitatively equivalent to the first one) and a comparator product.
Timeline
- Start
- 1999-11
- Primary completion
- 2000-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gefitinib | Small molecule | — | — |
| Comparator | Kiddi® Pharmaton Fizz | Unknown | — | — |
Indications
No indication recorded.